Compounds > (3h)2-carbomethoxy-3-(4-fluorophenyl)tropane

Page last updated: 2024-08-26

(3h)2-carbomethoxy-3-(4-fluorophenyl)tropane and Parkinsonian Disorders

(3h)2-carbomethoxy-3-(4-fluorophenyl)tropane has been researched along with Parkinsonian Disorders in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (66.67)	29.6817
2010's	3 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brown, CA; Karimi, M; Loftin, SK; Perlmutter, JS; Tian, L	1
Jia, J; Li, B; Liu, L; Sun, Z; Tian, J; Wang, X; Wang, Y; Zhang, J	1
Hayashi, T; Saiki, H; Takahashi, J; Takahashi, R	1
Agarwal, P; Dinelle, K; Hayflick, S; Heffernan, N; Hogarth, P; Kuriakose, R; MacLeod, P; McKenzie, J; Sossi, V; Stoessl, AJ	1
Brownell, AL; Chen, YC; Isacson, O; Jenkins, BG; Sanchez-Pernaute, R	1
Bendor, J; Bonab, AA; Elmaleh, DR; Fahey, MA; Fischman, AJ; Goodrich, C; Goulet, M; Lin, Z; Livni, E; Madras, BK; Meltzer, PC	1
Brownell, AL; Wang, JQ; Wang, X; Yu, M; Zhu, A	1
Brownell, AL; Cicchetti, F; Pellegrino, D; Saint-Pierre, M; Wang, X; Yu, M; Zhu, A	1
Adams, RJ; Alexander, M; Brasić, JR; Burton, NC; Chen, MK; Guilarte, TR; Kumar, A; Kuwabara, H; McGlothan, JL; Verina, T; Wong, DF; Zhou, Y	1

Other Studies

9 other study(ies) available for (3h)2-carbomethoxy-3-(4-fluorophenyl)tropane and Parkinsonian Disorders

Article	Year
In vivo measures of nigrostriatal neuronal response to unilateral MPTP treatment. Brain research, 2014, Jul-07, Volume: 1571 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cell Count; Chromatography, High Pressure Liquid; Cocaine; Corpus Striatum; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Functional Laterality; Macaca; Male; Neurons; Parkinsonian Disorders; Positron-Emission Tomography; Protein Binding; Substantia Nigra; Tyrosine 3-Monooxygenase; Vesicular Monoamine Transport Proteins	2014
Evaluation of nigrostriatal damage and its change over weeks in a rat model of Parkinson's disease: small animal positron emission tomography studies with [(11)C]beta-CFT. Nuclear medicine and biology, 2009, Volume: 36, Issue:8 Topics: Animals; Carbon Radioisotopes; Cocaine; Corpus Striatum; Disease Models, Animal; Humans; Male; Parkinsonian Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Wistar	2009
Objective and quantitative evaluation of motor function in a monkey model of Parkinson's disease. Journal of neuroscience methods, 2010, Jul-15, Volume: 190, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Brain Mapping; Carbon Radioisotopes; Cocaine; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dyskinesia, Drug-Induced; Macaca fascicularis; Parkinsonian Disorders; Positron-Emission Tomography; Severity of Illness Index; Video Recording	2010
Imaging striatal dopaminergic function in phospholipase A2 group VI-related parkinsonism. Movement disorders : official journal of the Movement Disorder Society, 2012, Volume: 27, Issue:13 Topics: Cocaine; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Group VI Phospholipases A2; Humans; Male; Parkinsonian Disorders; Positron-Emission Tomography; Young Adult	2012
Mapping dopamine function in primates using pharmacologic magnetic resonance imaging. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2004, Oct-27, Volume: 24, Issue:43 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Brain; Brain Mapping; Cerebrovascular Circulation; Cocaine; Dopamine; Dopamine Agents; Macaca fascicularis; Magnetic Resonance Imaging; Motor Activity; Parkinsonian Disorders; Positron-Emission Tomography; Radioligand Assay	2004
Dopamine transporter (DAT) inhibitors alleviate specific parkinsonian deficits in monkeys: association with DAT occupancy in vivo. The Journal of pharmacology and experimental therapeutics, 2006, Volume: 319, Issue:2 Topics: Animals; Cocaine; Dopamine Plasma Membrane Transport Proteins; Female; Macaca fascicularis; Male; Parkinsonian Disorders; Quinolines; Receptors, Dopamine D2; Receptors, Dopamine D3	2006
Evaluation of four pyridine analogs to characterize 6-OHDA-induced modulation of mGluR5 function in rat brain using microPET studies. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2007, Volume: 27, Issue:9 Topics: Adrenergic Agents; Animals; Brain; Cocaine; Functional Laterality; Image Processing, Computer-Assisted; Male; Oxidopamine; Parkinsonian Disorders; Positron-Emission Tomography; Pyridines; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate	2007
Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007, Volume: 48, Issue:7 Topics: Animals; Carbon Radioisotopes; Cocaine; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Hippocampus; Immunohistochemistry; Male; Nerve Degeneration; Neurons; Oxidopamine; Parkinsonian Disorders; Positron-Emission Tomography; Pyridines; Raclopride; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Dopamine D2; Receptors, Metabotropic Glutamate; Substantia Nigra; Tyrosine 3-Monooxygenase	2007
VMAT2 and dopamine neuron loss in a primate model of Parkinson's disease. Journal of neurochemistry, 2008, Volume: 105, Issue:1 Topics: Animals; Autoradiography; Brain; Carbon Isotopes; Carrier Proteins; Cocaine; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Glial Fibrillary Acidic Protein; Isoquinolines; Male; Neurons; Papio anubis; Parkinsonian Disorders; Positron-Emission Tomography; Raclopride; Tetrabenazine; Tyrosine 3-Monooxygenase; Vesicular Monoamine Transport Proteins	2008